论文部分内容阅读
目的:从药物经济学角度对西医组、中西医结合组及中医组3种治疗方案治疗的晚期乳腺癌患者进行费用-效果分析。方法:采用回顾性病例研究方法,筛选354例乳腺癌晚期患者,分为中医组、中西医结合组、西医组。对3组患者的治疗效果和治疗费用进行成本-效果分析。结果:3组患者疗效之间无显著性差异;中医组患者的治疗费用显著低于西医组和中西医结合组;同时,中医组费用-疗效比也显著低于西医组和中西医结合组。结论:中医疗法是经济、有效的晚期乳腺癌治疗方案。
OBJECTIVE: To analyze the cost-effectiveness of advanced breast cancer patients treated with three kinds of treatment regimens from western medicine group, traditional Chinese and western medicine combined group and traditional Chinese medicine group from the perspective of pharmacoeconomics. Methods: A retrospective case study was conducted to screen 354 patients with advanced breast cancer who were divided into traditional Chinese medicine group, traditional Chinese medicine and western medicine group, western medicine group. Cost-effectiveness analysis of treatment and treatment costs for 3 groups of patients. Results: There was no significant difference in curative effect between the three groups. The cost of treatment in TCM group was significantly lower than that in Western medicine group and Integrative Chinese medicine group. Meanwhile, the cost-effective ratio in TCM group was significantly lower than that in Western medicine group and Integrative medicine group. Conclusion: Chinese medicine therapy is an economical and effective treatment for advanced breast cancer.